Quick Answer
Journey Medical Corp reported Revenue (ASC 606) of $61.24 million for fiscal year 2025.
Journey Medical Corp Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $61.24M | +11.1% |
| 2024 | $55.13M | -7.6% |
| 2023 | $59.66M | -16.0% |
| 2022 | $71.00M | +12.5% |
| 2021 | $63.13M | +41.8% |
| 2020 | $44.53M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $17.02M | +16.4% | +13.4% |
| June 30, 2025 | $15.01M | +1.0% | +14.2% |
| March 31, 2025 | $13.14M | +0.8% | -10.2% |
| September 30, 2024 | $14.63M | -4.3% | -1.5% |
| June 30, 2024 | $14.86M | -12.4% | +14.0% |
| March 31, 2024 | $13.03M | +7.1% | -14.7% |
| September 30, 2023 | $15.28M | -4.8% | -9.9% |
| June 30, 2023 | $16.96M | -7.0% | +39.4% |
- Journey Medical Corp showed an increase of +11.1% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2020–2025 period, Journey Medical Corp’s revenue (asc 606) has grown by 37.5% (from $44.53 million to $61.24 million).
- The most recent figure is from Journey Medical Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: